Travere Therapeutics (TVTX) FCF Margin (2013 - 2026)
Travere Therapeutics (TVTX) posted FCF Margin of 48.59% for Q3 2026, up 39.99 percentage points from 8.60% a year earlier and up 20.77 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) FCF Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, FCF Margin at Travere Therapeutics was 27.12%, up 40.61 percentage points year-over-year; for FY2025, it was 7.70%, up 109.54 percentage points from FY2024.
- Annual FCF Margin has increased for three consecutive years, with a five-year change of +32.66 percentage points (FY2020 to FY2025).
- In prior years, Travere Therapeutics' FCF Margin was -101.84% in FY2024 (+122.63 pp), -224.48% in FY2023 (+14.00 pp) and -238.48% in FY2022.
- The Q3 2026 figure stands as the highest quarterly FCF Margin in data going back to Q4 2013.
- On a year-over-year basis, FCF Margin has increased in each of the last 13 quarters, with an average year-over-year change of +83.01 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2022, with a gain of 475.77 percentage points; the weakest was Q4 2021, with a drop of 702.57 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was 27.81% (Q2 2026), -31.73% (Q1 2026) and 46.79% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 48.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 48.59% |
| Jun 30, 2026 | 27.81% |
| Mar 31, 2026 | -31.73% |
| Dec 31, 2025 | 46.79% |
| Sep 30, 2025 | 8.60% |
| Jun 30, 2025 | 4.35% |
| Mar 31, 2025 | -51.62% |
| Dec 31, 2024 | -47.76% |
| Sep 30, 2024 | -67.58% |
| Jun 30, 2024 | -74.52% |
| Mar 31, 2024 | -287.63% |
| Dec 31, 2023 | -142.92% |
| Sep 30, 2023 | -200.67% |
| Jun 30, 2023 | -273.05% |
| Mar 31, 2023 | -321.42% |
| Dec 31, 2022 | -261.54% |
| Sep 30, 2022 | -327.80% |
| Jun 30, 2022 | -128.60% |
| Mar 31, 2022 | -236.85% |
| Dec 31, 2021 | -737.31% |
API Access
Travere Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();